FluSure XP/FarrowSure Gold

ZOETIS INC.
333 PORTAGE STREET, KALAMAZOO, MI, 49007
Telephone: 269-359-4414
Customer Service: 888-963-8471
Website: www.zoetis.com
THIS SERVICE AND DATA ARE PROVIDED "AS IS". DVMetrics assumes no liability, and each user assumes full risk, responsibility, and liability, related to its use of the DVMetrics service and data. See the Terms of Use for further details.
FluSure XP®/FarrowSure® GOLD

Zoetis

Parvovirus-Swine Influenza Vaccine, H1N1 & H1N2 & H3N2

Killed Virus

Erysipelothrix Rhusiopathiae-Leptospira Canicola-Grippotyphosa-Hardjo-Icterohaemorrhagiae-Pomona Bacterin

For use in swine only

For veterinary use only

For vaccination of healthy breeding swine, including pregnant sows and gilts, as an aid in preventing respiratory disease caused by swine influenza A viruses H1N1, H1N2 and H3N2, reproductive failure caused by PPV, and disease caused by Erysipelothrix rhusiopathiae, Leptospira canicola, L. grippotyphosa, L. hardjo, L. icterohaemorrhagiae and L. pomona. An 18-week duration of immunity following vaccination has been demonstrated against erysipelas. This product contains the following Influenza A Virus isolates: A/Swine/Iowa/110600/2000 (H1N1); A/Swine/Oklahoma/0726H/2008 (H1N2); A/Swine/North Carolina/394/2012 (H3N2); and A/Swine/Minnesota/872/2012 (H3N2).

Directions: Aseptically rehydrate the freeze-dried vaccine with the liquid component provided, shake well, and administer 2 mL intramuscularly. Healthy swine should receive 2 doses 3-5 weeks apart with the second dose administered 2-4 weeks prior to breeding. Healthy gilts, however, should receive the second dose as near as possible to 14 days prior to breeding. Revaccination with a single dose is recommended prior to subsequent breedings. Boars should be revaccinated semiannually.

Precautions: Store at 2°-7°C. Do not freeze. Use entire contents when first opened. Sterilized syringes and needles should be used to administer this vaccine. Do not vaccinate within 21 days before slaughter. Contains gentamicin as preservative. Temporary swelling at the injection site may be observed. As with many vaccines, anaphylaxis may occur after use. Initial antidote of epinephrine is recommended and should be followed with appropriate supportive therapy.

Technical inquiries should be directed to Zoetis Inc. Veterinary Services, (888) 963-8471 (USA), (800) 461-0917 (Canada).

U.S. Veterinary License No. 190

Zoetis Inc., Kalamazoo, MI 49007, USA



Code



50-dose vial of vaccine, rehydrate to 100 mL

100 mL vial of liquid component for use as diluent

49G6.2A

50050300

250-dose vial of vaccine, rehydrate to 500 mL

500 mL vial of liquid component for use as diluent

49G6.2B

50050500

CPN: 3690248.5